EUGIA PHARMA's Tranexamic Acid Supplement Receives FDA AP Status
EUGIA PHARMA's application for a supplement of Tranexamic Acid has received FDA approval status.
Asset / Drug
Drug and asset intelligence for EUGIA with 6 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Chemotherapy
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.